NCT00840242

Smoking Reduction or Cessation With Nicotine Replacement Therapy

Smoking Reduction or Cessation With Nicotine Replacement Therapy. A Placebo Controlled Double Blind Trial With Nicotine Gum or Inhaler.

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 314 (actual)
• Sponsor: McNeil AB · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to test the success rate of smoking reduction or cessation with different nicotine products.

Detailed description

To test if smoking reduction or cessation is induced with different nicotine products and to investigate the possible health benefits of smoking reduction

Conditions

• Smoking Cessation

Interventions

Type	Name	Description
DRUG	Nicotine gum	8-12 pieces per day, maximum 24 daily
DRUG	Placebo gum	8-12 pieces per day, maximum 24 daily
DRUG	Nicotine inhaler	6-12 cartridges per day, maximum 12 daily
DRUG	Placebo inhaler	6-12 cartridges per day, maximum 12 daily

Timeline

• Start date: 1999-02-01
• Primary completion: 2000-05-01
• Completion: 2000-05-01
• First posted: 2009-02-10
• Last updated: 2012-04-25

Locations

2 sites across 1 country: Czechia